Burgess Paul D.
Insider CIK 1744627 · TBIO Chief Operating Officer, CLO · CERE See Remarks · KLRA See Remarks
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| KLRA Kailera Therapeutics, Inc. | A Award deriv | 2026-04-16 | 2026-04-20 | 100,000 | — | $0 | 100,000 | SEC↗ |
| KLRA Kailera Therapeutics, Inc. | A Award deriv | 2026-04-16 | 2026-04-20 | 100,000 | — | $0 | 100,000 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | D To issuer deriv | 2024-08-01 | 2024-08-05 | 81,065 | — | $0 | 0 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | D To issuer deriv | 2024-08-01 | 2024-08-05 | 95,931 | — | $0 | 0 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | D To issuer | 2024-08-01 | 2024-08-05 | 45,727 | — | $0 | 0 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | A Award deriv | 2024-01-19 | 2024-01-23 | 81,065 | — | $0 | 81,065 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise deriv | 2023-12-19 | 2023-12-21 | 23,847 | — | $0 | 0 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise | 2023-12-19 | 2023-12-21 | 23,847 | — | $0 | 45,727 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | P Buy | 2023-08-04 | 2023-08-07 | 21,880 | $22.93 | $501.7K | 21,880 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | A Award deriv | 2023-07-03 | 2023-07-06 | 23,847 | — | $0 | 23,847 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | A Award deriv | 2023-07-03 | 2023-07-06 | 95,931 | — | $0 | 95,931 | SEC↗ |
| TBIO Translate Bio, Inc. | S Sale deriv | 2021-09-14 | 2021-09-14 | 150,000 | — | $0 | 0 | SEC↗ |
| TBIO Translate Bio, Inc. | S Sale deriv | 2021-09-14 | 2021-09-14 | 90,000 | — | $0 | 0 | SEC↗ |
| TBIO Translate Bio, Inc. | S Sale deriv | 2021-09-14 | 2021-09-14 | 150,000 | — | $0 | 0 | SEC↗ |
| TBIO Translate Bio, Inc. | S Sale deriv | 2021-09-14 | 2021-09-14 | 69,953 | — | $0 | 0 | SEC↗ |
| TBIO Translate Bio, Inc. | S Sale deriv | 2021-09-14 | 2021-09-14 | 219,652 | — | $0 | 0 | SEC↗ |
| TBIO Translate Bio, Inc. | S Sale | 2021-09-14 | 2021-09-14 | 71,833 | $38.00 | $2.73M | 0 | SEC↗ |
| TBIO Translate Bio, Inc. | A Award deriv | 2021-03-09 | 2021-03-09 | 90,000 | — | $0 | 90,000 | SEC↗ |
| TBIO Translate Bio, Inc. | A Award deriv | 2020-03-03 | 2020-03-05 | 150,000 | — | $0 | 150,000 | SEC↗ |
| TBIO Translate Bio, Inc. | A Award deriv | 2019-03-08 | 2019-03-12 | 150,000 | — | $0 | 150,000 | SEC↗ |